Event-Driven Stocks

KINETA, INC./DE

KANT

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs2 good3 warning2 severedetails ↓

Financials

SEC XBRL · annual
 FY24FY23FY22FY21FY20FY19
Revenue$0$5.4M$2.0M$8.0M$6.9M$5.0M
Operating income−$13.5M−$15.7M−$41.5M−$11.1M−$55.6M−$15.1M
Net income−$17.1M−$14.1M−$63.4M−$11.8M−$57.5M−$14.4M
Total assets$1.0M$10.3M$17.4M$13.4M$114.8M$84.7M
Total liabilities$12.9M$7.2M$12.9M$25.3M$58.6M$22.3M
Equity−$12.0M$2.9M$4.4M−$12.1M$56.2M$62.4M
EPS (diluted)$-1.42$-1.28$-12.87$-2.71
Shares out.11.0M8.5M10.8M10.2M52.1M51.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2024
Operating margin
Net margin
Return on equity
142.4%
Return on assets
−1681.3%
Return on capital (ROCE)
Liabilities / assets
1264.6%
Debt / equity
Book value / share
$-1.10
Revenue growth (YoY)
−100.0%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2024
Altman Z″ (distress)
-751.82distress
Accruals / assets
546.1%clean
Piotroski F-Score
1/8weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
30
/ 100
Profitability 50Growth 0Catalyst 33Earnings quality 67Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

2 severe3 warning2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
Jun 30, 2025561.0-99.3%
Jun 13, 20257,7421.0+72.8%
May 30, 20254,4801.0-76.6%
May 15, 202519,1282.4+40.7%
Apr 30, 202513,5941.0+280.4%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.